Factors Affecting Drug‐Development Strategies in Asian Global Clinical Trials for Drug Approval in Japan

We assessed the current status of Asian global clinical trials (GCTs) and factors, such as therapeutic areas, main metabolic enzymes targeted, approval status in the United States or the European Union, development strategies, influencing drug‐development strategies in Asian GCTs and in general GCTs...

Descripción completa

Detalles Bibliográficos
Autores principales: Asano, Kunihito, Uyama, Yoshiaki, Tohkin, Masahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5866961/
https://www.ncbi.nlm.nih.gov/pubmed/29139198
http://dx.doi.org/10.1111/cts.12520

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5866961/
https://www.ncbi.nlm.nih.gov/pubmed/29139198
http://dx.doi.org/10.1111/cts.12520

Ejemplares similares